EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries
EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries
NCT ID: NCT00896337 Phase: PHASE3 Status: COMPLETED Enrollment: 125 Completion: 2013-12
Conditions
Iliac Artery Stenosis
Interventions
Epic™ Nitinol Stent System, Anti-platelet therapy, Anti-coagulation therapy
Summary
The ORION study is being conducted to determine whether the Epic™ Nitinol Stent for primary stenting of iliac atherosclerotic lesions shows acceptable performance at 9 months.
Primary Outcome
Device- and/or Procedure-related Major Adverse Events (MAE)